跳至主要内容
临床试验/CTRI/2019/04/018818
CTRI/2019/04/018818尚未招募未知

Effect of depression on health related quality of life and adherence in chronic myeloid leukemia patients on Imatinib or Nilotinib - CMLDHA

Jamia Hamdard0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
Jamia Hamdard

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Diagnosis of Ph positive CML patients in chronic phase (CP) .
  • 2)Patients on imatinib or nilotinib first line therapy for minimum six month duration.
  • 3)Patientâ??s age must be of greater than 18 years .

排除标准

  • 1)Patients with a history of another primary malignancy that is clinical significant or requires active intervention.
  • 2)Patients unwilling to give the informed consent or unable to comply with the protocol.
  • 3)Patients who are on any antidepressants are also excluded.

研究者

发起方
Jamia Hamdard

相似试验